Monday Jun 22 | BNET
Pfizer Exec: Company Approved of Off-Label Bextra Promotion
Mary Holloway , the Pfizer regional manager who was sentenced last week for her role in a rogue operation that promoted Bextra for off-label uses such as post-operative pain, had the support of her superiors, she told Massachusetts federal district court.
Pfizer - Bextra: drug rep manager gets fine and probation
A Branchburg, NJ, woman was sentenced today for violating the Food, Drug and Cosmetic Act, for marketing the drug Bextra for uses and dosages that were not approved by the Food and Drug Administration.
Institute of Food Technologists
Natural Therapeutic Treatments for Arthritis
New natural treatments may help improve the quality of life for more than 21 million osteoarthritis sufferers, according to new research presented at the 2009 Institute of Food Technologists Annual Meeting and Food Expo.
Vioxx 'loyalty program' to lift sales
PHARMACEUTICAL giant Merck & Co planned to set up patient loyalty programs with the public goal of increasing "quality of life" but privately to "improve patient compliance" and double the "sales potential" of its anti-arthritis drug Vioxx.
Potential Lung Disease Biomarkers Yield Clues To COX-2 Inhibitor Side Effects
Main Category: Heart Disease Also Included In: Respiratory / Asthma ; Clinical Trials / Drug Trials ; Pain / Anesthetics Article Date: 05 May 2009 - 4:00 PDT In searching for a simple way to identify individuals with smoking-related lung injury, scientists at Weill Cornell Medical College have stumbled upon a potential explanation for why the class ...
Potential lung disease biomarkers yield clues to COX-2 inhibitor side effects
In searching for a simple way to identify individuals with smoking-related lung injury, scientists at Weill Cornell Medical College have stumbled upon a potential explanation for why the class of pain-relievers known as COX-2 inhibitors increases the risk of heart problems among users.
Document Shows Rogue Bextra Operation Inside Pfizer
The "information" document filed by federal prosecutors against Mary Holloway describes what appears to be a rogue sales unit inside Pfizer dedicated to selling the painkiller Bextra off-label and at unapproved doses.
Federal Bureau of Investigation
Pharmaceutical Company Manager Pleads Guilty to Off-Label Marketing
A Branchburg, NJ, woman agreed to plead guilty to violating the Food, Drug and Cosmetic Act, for marketing the drug Bextra for uses and dosages that were not approved by the Food and Drug Administration.
A Listing of the Twenty-One Fabricated Studies by Dr. Scott Reuben
The health community is up in arms over the discovery that a highly-respected and influential clinical researcher, Dr.
Questions About Retracted Studies Could Hurt Perception of Painkillers
A prominent pain doctor allegedly faked 21 studies about various drugs. With several questionable studies released in recent years, who can consumers trust? Colleagues Are Shocked Scott S. Reuben, former chief ...
Mass. doctor accused of fabricating pain studies
A Massachusetts anesthesiologist has been accused of fabricating results in nearly two dozen published studies that claimed to show after-surgery benefits from painkillers including Vioxx and Celebrex.
The Wall Street Journal is reporting that pharmaceutical giant Pfizer are about to settle a legal case brought by the US Government over illegal promotion of their now withdrawn painkiller Bextra for a ...
How Pfizer Hid a $2.3 Bill. Bextra Settlement in Plain Sight
BNET pointed out today that the announcement of Pfizer 's acquisition of Wyeth formed a welcome distraction from the news that the company was also paying a $2.3 billion settlement to make the Department of ...
Federal Prosecutor Warns Drug Companies on Off-Label Promotion: "This Must Stop''
Laurie Magid, the acting U.S. attorney for Pennsylvania 's Eastern District, has written a strongly worded warning to drug companies that they must stop promoting off-label uses for drugs or face the ...
Pfizer to buy Wyeth for $68B; cut 8,000 jobs
No. 1 drugmaker Pfizer Inc. said Monday it is buying No. 12 Wyeth for $68 billion in a deal that ultimately will wipe out nearly 20,000 jobs but quickly boost Pfizer's revenue and profit and transform it ...
Drugmaker immunity is a poison pill
Here are four compelling reasons why Gov. Sonny Perdue's proposal to create a liability-free haven for drugmakers threatens the welfare of Georgians - - Vioxx, Rezulin, fen-phen and Bextra.
Pfizer Loses Lawsuit over Database
A California jury ordered Pfizer to pay $38 million to the Ischemia Research and Education Foundation , a medical-research nonprofit group, for stealing trade secrets to develop its "Bextra" analgesic.
California jury orders Pfizer to pay $38 million for stealing trade secrets
A California jury has ordered drugmaker Pfizer Inc. to pay US$38 million to a leading Bay Area medical research non-profit for stealing trade secrets to develop a pain relief drug.